Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Nov 28, 2016 at 7:15 AM EST

Short Sellers Hike Their Bets in Most Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest was mixed in the…

Chris Lange | Nov 23, 2016 at 11:09 AM EST

Juno Falls Sharply on Self-Imposed Clinical Hold

Juno Therapeutics Inc. (NASDAQ: JUNO) saw its shares hit a new 52-week low in Wednesday’s session after the company announced…

Chris Lange | Nov 23, 2016 at 10:22 AM EST

Why Eli Lilly Won’t Forget This Alzheimer’s Failure Anytime Soon

Eli Lilly & Co. (NYSE: LLY) is watching its shares in free fall on Wednesday, not from any election or…

Chris Lange | Nov 22, 2016 at 3:29 PM EST

Skyline Medical Doubles on Canada Deal

Skyline Medical Inc. (NASDAQ: SKLN) is watching its shares more than double in Tuesday’s session after the company issued a…

Chris Lange | Nov 22, 2016 at 10:43 AM EST

Amedica Slides on Mixed FDA Updates

Amedica Corp. (NASDAQ: AMDA) is watching its shares drop on Tuesday despite receiving mixed news from the U.S. Food and…

Chris Lange | Nov 22, 2016 at 5:59 AM EST

Oragenics Practically Doubles on FDA Decision

Oragenics Inc. (NYSEMKT: OGEN) saw its shares practically double late on Monday, and even continue climbing after the trading session…

Jon C. Ogg | Nov 21, 2016 at 12:46 PM EST

Positive Analyst Ratings Not Enough to Drive Myovant Sciences Higher

Myovant Sciences Ltd. (NYSE: MYOV) priced its initial public offering of 14.5 million common shares on October 27, 2016. Now its…

Chris Lange | Nov 21, 2016 at 10:04 AM EST

Acorda Slides on Clinical Study Update

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is watching its shares slide on Monday after the company gave an update on a…

Chris Lange | Nov 19, 2016 at 5:10 PM EST

Aclaris Files for Secondary Offering

Aclaris Therapeutics saw its shares make a handy gain on Friday after the company announced the pricing of its secondary…

Chris Lange | Nov 19, 2016 at 5:05 PM EST

EyeGate Pharma Rises After FDA Meeting

Eyegate Pharmaceuticals saw its shares make a strong gain to close out the week after the company announced an update…

Jon C. Ogg | Nov 19, 2016 at 10:06 AM EST

Why NovoCure Shares Could Double, or Rise Even More

With the market effectively at all-time highs after the election, investors are looking for new ideas to generate income or…

Chris Lange | Nov 16, 2016 at 11:35 AM EST

Aurinia Pharmaceuticals Rises on Positive Mid-Stage Update

Shares of Aurinia Pharmaceuticals saw a handy gain on Wednesday after the company gave an update on its lupus nephritis…

Chris Lange | Nov 16, 2016 at 10:35 AM EST

AnaptysBio Files for IPO

AnaptysBio has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Lee Jackson | Nov 16, 2016 at 8:25 AM EST

Trump Corporate Tax Cuts Could Really Help These 4 Large Cap Companies

A new research report from JPMorgan makes the case that lowering the corporate tax rate could be huge for many…

Chris Lange | Nov 15, 2016 at 12:25 PM EST

Synthetic Biologics Prices Secondary Offering

Synthetic Biologics has announced the pricing for its secondary offering and expects to make $25 million from the offering.

1 … 183 184 185 186 187 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Hike Their Bets in Most Major Pharma Stocks

Juno Falls Sharply on Self-Imposed Clinical Hold

Why Eli Lilly Won’t Forget This Alzheimer’s Failure Anytime Soon

Skyline Medical Doubles on Canada Deal

Amedica Slides on Mixed FDA Updates

Oragenics Practically Doubles on FDA Decision

Positive Analyst Ratings Not Enough to Drive Myovant Sciences Higher

Acorda Slides on Clinical Study Update

Aclaris Files for Secondary Offering

EyeGate Pharma Rises After FDA Meeting

Why NovoCure Shares Could Double, or Rise Even More

Aurinia Pharmaceuticals Rises on Positive Mid-Stage Update

AnaptysBio Files for IPO

Trump Corporate Tax Cuts Could Really Help These 4 Large Cap Companies

Synthetic Biologics Prices Secondary Offering

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Hike Their Bets in Most Major Pharma Stocks

Juno Falls Sharply on Self-Imposed Clinical Hold

Why Eli Lilly Won’t Forget This Alzheimer’s Failure Anytime Soon

Skyline Medical Doubles on Canada Deal

Amedica Slides on Mixed FDA Updates

Oragenics Practically Doubles on FDA Decision

Positive Analyst Ratings Not Enough to Drive Myovant Sciences Higher

Acorda Slides on Clinical Study Update

Aclaris Files for Secondary Offering

EyeGate Pharma Rises After FDA Meeting

Why NovoCure Shares Could Double, or Rise Even More

Aurinia Pharmaceuticals Rises on Positive Mid-Stage Update

AnaptysBio Files for IPO

Trump Corporate Tax Cuts Could Really Help These 4 Large Cap Companies

Synthetic Biologics Prices Secondary Offering

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check